BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33108911)

  • 1. Clinical significance of CD200 expression in newly diagnosed multiple myeloma patients and dynamic changing during treatment.
    Shi Q; Wu C; Han W; Zhao S; Wu Y; Jin Y; Qu X; Li J; Zhang R; Chen L
    Leuk Lymphoma; 2021 Mar; 62(3):709-715. PubMed ID: 33108911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD200 Expression on Plasma Cell Myeloma Cells is Associated with the Efficacies of Bortezomib, Lenalidomide and Thalidomide.
    Tazawa S; Shiozawa E; Homma M; Arai N; Kabasawa N; Kawaguchi Y; Fujiwara S; Okino K; Kobayashi K; Yamochi T; Tate G; Nakamaki T; Takimoto M
    J Clin Exp Hematop; 2015; 55(3):121-6. PubMed ID: 26763359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between Expression of CD200 and Regulatory T Cells in Multiple Myeloma and Its Significance in Prognostic Stratification].
    Zhu MX; Wan WL; Li HS; Wang YF; Wang J; Ling HS; Yan XX; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1427-1432. PubMed ID: 27784369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CD200 protein, bad prognostic in patients with multiple myeloma].
    Vela-Ojeda J; García-Ruiz Esparza MA; Padilla-González Y; Pérez-Retiguin F; Reyes-Maldonado E; Maillet D; Montiel-Cervantes LA
    Rev Med Inst Mex Seguro Soc; 2015; 53(4):438-43. PubMed ID: 26177431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low absolute CD4
    Gu Y; Jin Y; Ding J; Yujie W; Shi Q; Qu X; Zhao S; Li J; Lijuan C
    Leuk Lymphoma; 2020 Aug; 61(8):1869-1876. PubMed ID: 32324088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD200 is a new prognostic factor in multiple myeloma.
    Moreaux J; Hose D; Reme T; Jourdan E; Hundemer M; Legouffe E; Moine P; Bourin P; Moos M; Corre J; Möhler T; De Vos J; Rossi JF; Goldschmidt H; Klein B
    Blood; 2006 Dec; 108(13):4194-7. PubMed ID: 16946299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prognostic significance of dynamic monitoring of minimal residual disease (MRD) status in patients with newly-diagnosed multiple myeloma].
    Yang PY; Liu MM; Fan HQ; Yang YP; Han W; Yu XY; Yue TT; Su KJ; Guo Q; Gao SJ; Jin FY
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):584-588. PubMed ID: 32397022
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation between Clinical Factors and Prognosis in Newly Diagnosed Multiple Myeloma.
    Zhao XQ; Zhao SY; Chen WX; Liu XW; Yan HX; Lou YJ
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):601-605. PubMed ID: 32703344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of regulatory T cells, CD200 and TIM3 expression in cytogenetically normal acute myeloid leukemia.
    Zahran AM; Mohammed Saleh MF; Sayed MM; Rayan A; Ali AM; Hetta HF
    Cancer Biomark; 2018; 22(3):587-595. PubMed ID: 29843224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD200 genotype is associated with clinical outcome of patients with multiple myeloma.
    Gonzalez-Montes Y; Osca-Gelis G; Rodriguez-Romanos R; Villavicencio A; González-Bártulos M; Llopis F; Clapes V; Oriol A; Sureda A; Escoda L; Sarrà J; Garzó A; Lloveras N; Gómez B; Granada I; Gallardo D
    Front Immunol; 2024; 15():1252445. PubMed ID: 38455039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving minimal residual disease-negative by multiparameter flow cytometry may ameliorate a poor prognosis in MM patients with high-risk cytogenetics: a retrospective single-center analysis.
    Li H; Li F; Zhou X; Mei J; Song P; An Z; Zhao Q; Guo X; Wang X; Zhai Y
    Ann Hematol; 2019 May; 98(5):1185-1195. PubMed ID: 30721336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Leukocytes, B and T Lymphocytes, and expression of CD200 and CD23 on B lymphocytes in Patients with Atopic Dermatitis on Dupilumab Therapy-Pilot Study.
    Čelakovská J; Čermáková E; Boudková P; Andrýs C; Krejsek J
    Dermatol Ther (Heidelb); 2023 May; 13(5):1171-1192. PubMed ID: 37097547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of CD200 is associated with regulatory T cell expansion and disease progression in multiple myeloma.
    Aref S; Azmy E; El-Gilany AH
    Hematol Oncol; 2017 Mar; 35(1):51-57. PubMed ID: 26033514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic significance of CD200 expression and its stability in plasma cell myeloma.
    Douds JJ; Long DJ; Kim AS; Li S
    J Clin Pathol; 2014 Sep; 67(9):792-6. PubMed ID: 24958785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation of Peripheral Blood T Lymphocyte Subsets with Prognosis of Elderly Patients with Newly Diagnosed Multiple Myeloma].
    Ding J; Gu Y; Zhao SS; Wu YJ; Shi QL; Qu XY; Li JY; Chen LJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1876-1880. PubMed ID: 31839053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The prognostic relationship between CD56 expression and newly diagnosed multiple myeloma].
    Geng CY; Yang GZ; Wang HJ; Zhou HX; Zhang ZY; Jian Y; Chen WM
    Zhonghua Nei Ke Za Zhi; 2022 Feb; 61(2):164-171. PubMed ID: 35090251
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of minimal residual disease detection by multiparameter flow cytometry in newly diagnosed multiple myeloma: an analysis of 106 patients].
    Deng SH; Xu Y; Sui WW; Wang HJ; Li ZJ; Wang TY; Liu W; Huang WY; Lyu R; Li J; Fu MW; Zou DH; An G; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2018 May; 39(5):376-381. PubMed ID: 29779345
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200.
    Mahadevan D; Lanasa MC; Farber C; Pandey M; Whelden M; Faas SJ; Ulery T; Kukreja A; Li L; Bedrosian CL; Zhang X; Heffner LT
    J Immunother Cancer; 2019 Aug; 7(1):227. PubMed ID: 31443741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of CD56 and CD19 in Patients with Newly Diagnosed Multiple Myeloma and Their Relationship with Karyotypes and Prognosis].
    Qiu Q; Zhu P; Wang MJ; Lu XZ; Dong YJ; Sun YH; Wang LH; Zhang Y; Bu DF; Wang WS; Liang ZY; Liu W; Qiu ZX; Ou JP; Cen XN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1071-8. PubMed ID: 27531777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD200 expression in hematopoietic neoplasms: Beyond a marker for diagnosis of B-cell neoplasms.
    Staub RB; Marcondes NA; Rotta LN
    Crit Rev Oncol Hematol; 2021 Nov; 167():103509. PubMed ID: 34688895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.